Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker.
Hang-Korng EaBrenda KischkelTwinu Wilson ChirayathViola KlückCaroline AparicioHoang-Uyen LoeungPhilippe ManivetTim L Th A JansenMylène ZarkaFrédéric LiotéAugustin LatourteThomas BardinAlan GauffenicEric VicautTania Octavia CrișanMihai G NeteaPascal RichetteLeo A B JoostenPublished in: Annals of the rheumatic diseases (2024)
Gout flare involves multiple inflammatory mediators that may be used as potential therapeutic targets.